1,125
Views
116
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates

, , , , , , , , , & show all
Pages 2156-2162 | Received 12 Aug 2007, Accepted 16 Sep 2008, Published online: 01 Jul 2009

References

  • Woo S B, Hellstein J W, Kalmar J R. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006; 144: 753–761
  • Migliorati C A, Siegel M A, Elting L S. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 2006; 7: 508–514
  • Bamias A, Kastritis E, Bamia C, Moulopoulos L A, Melakopoulos I, Bozas G, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005; 23: 8580–8587
  • Dimopoulos M A, Kastritis E, Anagnostopoulos A, Melakopoulos I, Gika D, Moulopoulos L A, et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica 2006; 91: 968–971
  • Zervas K, Verrou E, Teleioudis Z, Vahtsevanos K, Banti A, Mihou D, et al. Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients. Br J Haematol 2006; 134: 620–623
  • Durie B G, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005; 353: 99–102
  • Sietsema W K, Ebetino F H, Salvagno A M, Bevan J A. Antiresorptive dose-response relationships across three generations of bisphosphonates. Drugs Exp Clin Res 1989; 15: 389–396
  • Wood J, Bonjean K, Ruetz S, Bellahcène A, Devy L, Foidart J M, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002; 302: 1055–1061
  • Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006; 24: 945–952
  • Marx R E, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. Oral Maxillofac Surg 2005; 63: 1567–1575
  • Dannemann C, Grätz K W, Riener M O, Zwahlen R A. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Bone 2007; 40: 828–834
  • Hansen T, Kunkel M, Weber A, Kirkpatrick C J. Osteonecrosis of the jaws in patients treated with bisphosphonates–histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 2006; 35: 155–160
  • Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O. Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 2004; 117: 440–441
  • Pulverer G, Schätt-Gerowitt H, Schaal K P. Human cervicofacial actinomycoses: microbiological data for 1997 cases. Clin Infect Dis 2003; 37: 490–497
  • Kyle R A, Yee G C, Somerfield M R, Flynn P J, Halabi S, Jagannath S, et al. American society of clinical oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 2007; 25: 2464–2472
  • Petrucci M T, Gallucci C, Agrillo A, Mustazza M C, Foà R. Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica 2007; 92: 1289–1290
  • Freiberger J J, Padilla-Burgos R, Chhoeu A H, Kraft K H, Boneta O, Moon R E, et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 2007; 65: 1321–1327
  • Walter C, Grötz K A, Kunkel M, Al-Nawas B. Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 2007; 15: 197–202
  • Marubini E, Valsecchi M G. Analysing Survival Data for Clinical Trials and Observational Studies. John Wiley, Chichester, UK 1995
  • Essebag V, Genest J, Suissa S, Pilote L. The nested case–control study in cardiology. Am Hearth J 2003; 146: 581–590
  • Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8: 551–561
  • SAS Institute Inc. SAS/STAT User's Guide, Version 6. Vol 1 and 2. 4th edn. SAS Institute Inc, Cary, NC, USA 1989
  • The R Project for Statistical Computing. 2008, Available at: http://www.r-project.org/. Accessed March
  • Richardson D B. An incidence density sampling program for nested case–control analyses. Occup Environ Med 2004; 61: e59
  • Firth D. Bias reduction of maximum likelihood estimates. Biometrika 1993; 80: 27–38
  • Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics 2001; 7: 114–119
  • Heinze G. Technical Report 10/1999: The Application of Firth's Procedure to Cox and Logistic Regression. Section of Clinical Biometrics, Department of Medical Computer Sciences, University of Vienna, ViennaAustria
  • Heinze G, Ploner M. SAS and SPLUS programs to perform Cox regression without convergence problems. Comput Methods Programs Biomed 2002; 67: 217–223
  • Heinze G. Technical Report 1/2006 FC06: A SAS Macro for Cox regression with Firth's Penalization. Section of Clinical Biometrics, Core Unit for Medical Statistics and Informatics, Medical University of Vienna, ViennaAustria
  • Angelillo I F, Nobile C G, Pavia M. Survey of reasons for extraction of permanent teeth in Italy. Comm Dent Oral Epidemiol 1996; 24: 336–340
  • Dodson T B, Raje N S, Caruso P A, Rosenberg A E. Case records of the Massachusetts General Hospital. Case 9–2008. A 65-year-old woman with a nonhealing ulcer of the jaw. N Engl J Med 2008; 358: 1283–1291

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.